<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is now extensive evidence to show that the cytokine interleukin-1 (IL-1) contributes directly to reversible and permanent ischemic brain damage in rodents </plain></SENT>
<SENT sid="1" pm="."><plain>Because interleukin-18 (IL-18) shares many structural and functional similarities with IL-1, the authors tested the hypothesis that IL-18 contributes directly to ischemic brain damage in mice exposed to focal, reversible (15-minute or 30-minute) middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>IL-18 expression was not induced acutely by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, and deletion of the IL-18 gene (IL-18 knockout mice) did not affect <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="3" pm="."><plain>The present results suggest that IL-18 does not contribute to <z:hpo ids='HP_0011009'>acute</z:hpo> ischemic brain damage </plain></SENT>
</text></document>